leadf
logo-loader
CSE:BRAX OTC:BRAXF FRA:496

Braxia Scientific Corp.

Receive alerts
Market:
CSE
Market Cap:
$33.68 m
Price
0.20 CAD
Change
0.00%
52 weeks high
0.82
52 weeks low
0.19

In brief

Braxia Scientific is leading the way in providing people who suffer from mental illness access to breakthrough treatments through our growing global network of multidisciplinary clinics while setting the standard of care. Braxia Scientific also aims to develop innovative ketamine and psychedelic drug formulations to provide high impact solutions for the future.

Snapshot

As one of the first psychedelic companies to go public, the firm’s network of ketamine clinics complements its sharp focus on research and development